While LC-MS greatly minimizes error rates, no test is completely free of false positives or negatives. We clearly indicate uncertainty ranges in our reports and focus only on biomarkers with validated clinical utility. Certain exposures may be difficult to measure if biomarkers are unstable or poorly characterized in the literature.
Comments
0 comments
Article is closed for comments.